Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTG713)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 March 2024
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTG701)Product type:GuidanceProgramme:HealthTech guidancePublished: 15 November 2023
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment (HTG694)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 September 2023
Transcranial magnetic stimulation for auditory hallucinations (HTG555)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 September 2020
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medicationStatus:Awaiting developmentProgramme:HealthTech guidanceExpected publication date: TBC